Taysha Gene Therapies (TSHA) Enterprise Value (2020 - 2026)
Taysha Gene Therapies' Enterprise Value was $1.76 billion in Q2 2026, up 454.7% from $317.25 million a year earlier and up 29.2% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Enterprise Value (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Taysha Gene Therapies' Enterprise Value was $866.19 million through Jun 30, 2026; for FY2025, it was $1.25 billion, up 479.1% from FY2024.
- Enterprise Value has now increased for three consecutive years, with a five-year compound annual growth rate of 41.8% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $215.52 million in FY2024 (+249.9%), $61.6 million in FY2023 (+437.9%), $11.45 million in FY2022 (-96.1%) and $296.48 million in FY2021 (+36.3%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value in data going back to Q3 2020.
- Compared with a year earlier, Enterprise Value has increased for five straight quarters, with growth averaging 222.2% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q4 2025 (growth of 479.1%); the worst was Q4 2022 (a decline of 96.1%).
- Per Business Quant data, TSHA's Enterprise Value in the three quarters before Q2 2026 was $1.36 billion (Q1 2026), $1.25 billion (Q4 2025) and $857.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Taysha Gene Therapies | 1.62 Bn | 1.62 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 857.98 Mn |
| Jun 30, 2025 | 317.25 Mn |
| Mar 31, 2025 | 257.74 Mn |
| Dec 31, 2024 | 215.52 Mn |
| Sep 30, 2024 | 380.64 Mn |
| Jun 30, 2024 | 278.35 Mn |
| Mar 31, 2024 | 412.76 Mn |
| Dec 31, 2023 | 61.60 Mn |
| Sep 30, 2023 | 232.94 Mn |
| Jun 30, 2023 | -2.56 Mn |
| Mar 31, 2023 | -12.65 Mn |
| Dec 31, 2022 | 11.45 Mn |
| Sep 30, 2022 | 42.53 Mn |
| Jun 30, 2022 | 83.72 Mn |
| Mar 31, 2022 | 151.58 Mn |
| Dec 31, 2021 | 296.48 Mn |
| Sep 30, 2021 | 524.97 Mn |
API Access
Taysha Gene Therapies Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();